electroCore to Participate in the 25th Annual Needham Virtual Healthcare Conference
electroCore (Nasdaq: ECOR) will participate in the 25th Annual Needham Virtual Healthcare Conference on April 15, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
electroCore (Nasdaq: ECOR) will participate in the 25th Annual Needham Virtual Healthcare Conference on April 15, 2026. Management presentation is scheduled for 2:15 pm ET, led by Joshua Lev, Interim President and Chief Financial Officer.
Investors can request one-on-one meetings via their Needham representative or by emailing investors@electrocore.com.
Details
News Market Reaction – ECOR
On Apr 8, the day this news came out, ECOR closed 7.45% below the previous close.
Data tracked by StockTitan Argus for the Apr 8 session.
Key Figures
- Conference date
- April 15, 2026
- Needham Virtual Healthcare Conference participation
- Presentation time
- 2:15 pm ET
- Scheduled company presentation at Needham conference
Historical Context
-
Post-hoc analysis of 35 mTBI/PTSD patients showed symptom reduction with nVNS.
-
New VP Sales and COO with 100,000 RSUs granted under inducement awards.
-
Two new U.S. patents expanded protection for nVNS platforms into the 2040s.
-
Record $32.0M net sales, improved EBITDA loss, and ~30% 2026 growth guidance.
-
Management participation at the 38th Annual Roth Conference with investor meetings.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
ROCKAWAY, N.J., April 08, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate at the Needham Virtual Healthcare Conference taking place virtually on April 15, 2026.
Joshua Lev, Interim President and Chief Financial Officer, will host a company presentation at 2:15 pm ET and participate in one-on-one meetings throughout the day.
DATE: April 15, 2026
TIME: 2:15 pm ET
Investors attending the conference who are interested in scheduling a meeting with management can do so by contacting their Needham representative, or by emailing ECOR Investor Relations at investors@electrocore.com.
About electroCore, Inc.
electroCore, Inc. is a bioelectronic technology company whose mission is to improve health and quality of life through innovative non-invasive bioelectronic technologies. The Company’s two leading prescription products, gammaCore® non-invasive vagus nerve stimulation (nVNS) and Quell® neurostimulator, treat chronic pain syndromes through non-invasive neuromodulation technology. Additionally, the company commercializes its handheld, and personal use Truvaga™ and TAC-STIM™ nVNS products utilizing bioelectronic technologies to promote general wellness and human performance.
For more information, visit www.electrocore.com.
Contact:
ECOR Investor Relations
(973) 302-9253
investors@electrocore.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.